REDEMPLO 25 mg/.5mL
plozasiran · INJECTION, SOLUTION · Arrowhead Pharmaceuticals, Inc.
No Recall History
Plain English
REDEMPLO is a injection, solution containing plozasiran at 25 mg/.5mL, taken subcutaneous. Manufactured by Arrowhead Pharmaceuticals, Inc..
Key Facts
- Brand Name
- REDEMPLO
- Generic Name
- plozasiran
- NDC Code (Product)
84141-025- Manufacturer
- Arrowhead Pharmaceuticals, Inc.
- Strength
- 25 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA219947
- Drug Class
- APOC-III-directed RNA Interaction [EPC]; Small Interfering RNA [EPC]
- Marketing Start
- 11/19/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is REDEMPLO used for?
REDEMPLO contains plozasiran. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is REDEMPLO a controlled substance?
REDEMPLO is not classified as a controlled substance by the DEA.
What is the generic name for REDEMPLO?
The generic name for REDEMPLO is plozasiran. There are no other listed brand versions of plozasiran.
What is the NDC code for REDEMPLO 25 mg/.5mL?
The NDC (National Drug Code) for REDEMPLO 25 mg/.5mL is 84141-025, listed by Arrowhead Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)